ATOPIC DERMATITIS ECZEMA

This study tested whether a team-based online care model works as well as in-person visits for managing atopic dermatitis (eczema). 300 patients were randomly assigned to either online or in-person care for 12 months. Researchers measured changes in disease severity, quality of l…

This study tested whether tofacitinib, a drug already approved for other conditions, is safe and helpful for people with Down syndrome who also have immune-related skin problems like eczema, psoriasis, or hair loss. The study included 47 adolescents and adults. Researchers measur…

This study tested a cream called ARQ-151 in 652 children aged 2 to 5 years with eczema (atopic dermatitis). The cream was applied once daily for 4 weeks. The goal was to see if it could clear or nearly clear the skin rash better than a cream with no active ingredient. The study i…

This study tested a cream called roflumilast (0.05%) applied once daily for 4 weeks in 101 infants aged 3 months to under 2 years with mild to moderate eczema. The main goal was to check for side effects and skin reactions. The cream is not a cure, but aims to ease symptoms safel…

This study looked at the long-term safety of a cream called roflumilast for people with mild to moderate eczema (atopic dermatitis). Over 1,200 children and adults applied the cream once daily for up to 52 weeks. The main goal was to track any side effects, with secondary goals m…

This study looked at how dupilumab affects the immune cells and genes inside the skin of people with moderate-to-severe eczema. Seventeen adults took the drug and had skin samples tested before and after 12 weeks of treatment. The goal was to understand how the medicine works at …